Related Experiment Videos
[Could it be an immune defect? Background and diagnosis]
1Medizinische Poliklinik-Innenstadt, Klinikum der LMU München. Rudolf.Gruber@med.uni-muenchen.de
MMW Fortschritte Der Medizin
|March 16, 2005
Summary
Early diagnosis of primary immunodeficiencies (PIDs) is crucial for preventing severe complications. Prompt medical evaluation and specific lab tests can lead to effective treatments, improving patient outcomes and quality of life.
Area of Science:
- Immunology
- Molecular Biology
- Clinical Diagnostics
Context:
- Modern immunological and molecular biological techniques enable diagnosis of approximately 100 primary immunodeficiencies (PIDs).
- Early diagnosis of PIDs is critical due to the risk of permanent damage or death from recurrent infections.
- Patients often present with non-specific symptoms like recurrent infections, complicating diagnosis.
Purpose:
- To highlight the importance of early diagnosis and treatment of primary immunodeficiencies.
- To outline diagnostic approaches, including initial screening and specific evaluations.
- To emphasize the potential for improved patient outcomes with timely intervention.
Summary:
- Approximately 100 PIDs are diagnosable using current laboratory techniques.
- Recurrent infections in PID patients can cause severe, lasting harm.
- Initial physician visits may involve non-specific symptoms, necessitating careful evaluation.
- Warning signs and family history should prompt basic tests like blood differentials and immunoglobulin levels.
- Further specific tests may be required based on initial findings.
- Early treatment, such as immunoglobulin therapy, can significantly improve quality of life.
- Bone marrow transplantation and gene therapy offer potential cures for some PIDs.
Impact:
- Facilitates timely and appropriate treatment for primary immunodeficiency disorders.
- Reduces long-term morbidity and mortality associated with PIDs.
- Enables patients with PIDs to lead more normal lives through effective management.
- Advances the potential for curative therapies like bone marrow transplantation and gene therapy for PIDs.